Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) (345099)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next deadline: Feb 20, 2024

Later deadlines: Mar 18, 2024, Jun 18, 2024, Jul 18, 2024, Oct 18, 2024, Nov 18, 2024

Grant amount: Up to US $650,000

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: The following deadlines apply to standard grant applications (due by 5:00 pm  local time of applicant organization:

* February 17,2023

* June 19, 2023

* October 18 2023

* February 20, 2024

* June 18, 2024

* October 18, 2024

The following deadlines apply to AIDS-related grant applications (due by 5:00 pm local time of applicant organization: 

* March 17, 2023 

* July 18, 2023

* November 17, 2023

* March 18, 2024

* July 18, 2024

* November 18, 2024

The purpose of this Funding Opportunity Announcement (FOA) is to  invite research grant applications that enable the collection of pilot data to support early stage testing of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) across the spectrum from pre-symptomatic to more severe stages of disease, and stimulate studies to enhance trial design and methods.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.